Effects of norepinephrine upon superficial layer neurons in the superior colliculus of the hamster: in vitro studies.
Intracellular recording techniques were used to evaluate the effects of norepinephrine (NE) on the membrane properties of superficial layer (stratum griseum superficiale and stratum opticum) superior colliculus (SC) cells. Of the 207 cells tested, 44.4% (N = 92) were hyperpolarized by > or = 3 mV and 8.7% (N = 18) were depolarized by > or = 3 mV by application of NE. Hyperpolarization induced by NE was dose dependent (EC50 = 8.1 microM) and was associated with decreased input resistance and outward current which had a reversal potential of -94.0 mV. Depolarization was associated with a very slight rise in input resistance and had a reversal potential of -93.1 mV for the single cell tested. Pharmacologic experiments demonstrated that isoproterenol, dobutamine, and p-aminoclonidine all hyperpolarized SC cells. These results are consistent with the conclusion that NE-induced hyperpolarization of SC cells is mediated by both alpha2 and beta1 adrenoceptors. The alpha1 adrenoceptor agonists, methoxamine and phenylephrine, depolarized 35% (6 of 17) of the SC cells tested by > or = 3 mV. Most of the SC cells tested exhibited responses indicative of expression of more than one adrenoceptor. Application of p-aminoclonidine or dobutamine inhibited transsynaptic responses in SC cells evoked by electrical stimulation of optic tract axons. Inhibition of evoked responses by these agents was usually, but not invariably, associated with a hyperpolarization of the cell membrane and a reduction in depolarizing potentials evoked by application of glutamate. The present in vitro results are consistent with those of the companion in vivo study which suggested that NE-induced response suppression in superficial layer SC neurons was primarily postsynaptic and chiefly mediated by both beta2 and beta1 adrenoceptors.
Tan
H
H
Department of Anatomy and Neurobiology, Medical College of Ohio, Toledo 43699-0008, USA.
Mooney
R D
RD
Rhoades
R W
RW
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D001262:Atenolol / Q000494:pharmacology; D003000:Clonidine / Q000031:analogs & derivatives / Q000494:pharmacology; D006224:Cricetinae; D004280:Dobutamine / Q000494:pharmacology; D019706:Excitatory Postsynaptic Potentials / Q000187:drug effects; D007545:Isoproterenol / Q000494:pharmacology; D008564:Membrane Potentials / Q000187:drug effects; D009474:Neurons / Q000187:drug effects*; D009638:Norepinephrine / Q000494:pharmacology*; D011941:Receptors, Adrenergic / Q000187:drug effects; D013477:Superior Colliculi / Q000166:cytology / Q000187:drug effects*
D011941:Receptors, Adrenergic; D004280:Dobutamine; D001262:Atenolol; C016986:apraclonidine; D007545:Isoproterenol; D003000:Clonidine; D009638:Norepinephrine